These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2525823

  • 1. D1 receptor activation enhances sciatic nerve stimulation-induced inhibition of nigrostriatal dopamine neurons.
    Kelland MD, Freeman AS, Chiodo LA.
    Synapse; 1989; 3(4):339-45. PubMed ID: 2525823
    [Abstract] [Full Text] [Related]

  • 2. SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons.
    Kelland MD, Freeman AS, Chiodo LA.
    Synapse; 1988; 2(4):416-23. PubMed ID: 2973142
    [Abstract] [Full Text] [Related]

  • 3. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 4. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK, Manzino L, Heikkila RE.
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [Abstract] [Full Text] [Related]

  • 5. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
    Turski WA, Cavalheiro EA, Ikonomidou C, Bortolotto ZA, Klockgether T, Turski L.
    Synapse; 1990 Oct; 5(2):113-9. PubMed ID: 2137942
    [Abstract] [Full Text] [Related]

  • 6. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
    Carlson JH, Bergstrom DA, Demo SD, Walters JR.
    Synapse; 1990 Oct; 5(2):83-93. PubMed ID: 2309160
    [Abstract] [Full Text] [Related]

  • 7. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 8. Effects of (+)-4-propyl-9-hydroxynaphthoxazine on midbrain dopamine neurons: an electrophysiological study.
    Kelland MD, Freeman AS, LeWitt PA, Chiodo LA.
    J Pharmacol Exp Ther; 1990 Oct 10; 255(1):276-84. PubMed ID: 1976800
    [Abstract] [Full Text] [Related]

  • 9. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
    Huang KX, Walters JR.
    J Pharmacol Exp Ther; 1992 Jan 10; 260(1):409-16. PubMed ID: 1530977
    [Abstract] [Full Text] [Related]

  • 10. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX, Walters JR.
    J Pharmacol Exp Ther; 1994 Dec 10; 271(3):1434-43. PubMed ID: 7996456
    [Abstract] [Full Text] [Related]

  • 11. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
    Carlson JH, Bergstrom DA, Weick BG, Walters JR.
    Synapse; 1987 Dec 10; 1(5):411-6. PubMed ID: 2975067
    [Abstract] [Full Text] [Related]

  • 12. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
    Merchant KM, Bush LG, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1990 Nov 10; 255(2):775-80. PubMed ID: 2147039
    [Abstract] [Full Text] [Related]

  • 13. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
    Ruskin DN, Bergstrom DA, Walters JR.
    J Neurophysiol; 2002 Jul 10; 88(1):487-96. PubMed ID: 12091570
    [Abstract] [Full Text] [Related]

  • 14. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May 10; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 15. Dopamine D1 heteroreceptors on striatonigral axons are not stimulated by endogeneous dopamine either tonically or after amphetamine: evidence from terminal excitability.
    Ryan LJ, Diana M, Young SJ, Groves PM.
    Exp Brain Res; 1989 May 10; 77(1):161-5. PubMed ID: 2529134
    [Abstract] [Full Text] [Related]

  • 16. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ, Albers LJ, Le H, Creese I.
    J Pharmacol Exp Ther; 1986 Sep 10; 238(3):846-54. PubMed ID: 3018223
    [Abstract] [Full Text] [Related]

  • 17. Control of the subthalamic innervation of substantia nigra pars reticulata by D1 and D2 dopamine receptors.
    Ibañez-Sandoval O, Hernández A, Florán B, Galarraga E, Tapia D, Valdiosera R, Erlij D, Aceves J, Bargas J.
    J Neurophysiol; 2006 Mar 10; 95(3):1800-11. PubMed ID: 16306171
    [Abstract] [Full Text] [Related]

  • 18. Activation of phosphatidylinositol-linked novel D1 dopamine receptors inhibits high-voltage-activated Ca2+ currents in primary cultured striatal neurons.
    Ma LQ, Liu C, Wang F, Xie N, Gu J, Fu H, Wang JH, Cai F, Liu J, Chen JG.
    J Neurophysiol; 2009 May 10; 101(5):2230-8. PubMed ID: 19225177
    [Abstract] [Full Text] [Related]

  • 19. Modulation of GABA release by dopamine in the substantia nigra.
    Matuszewich L, Yamamoto BK.
    Synapse; 1999 Apr 10; 32(1):29-36. PubMed ID: 10188635
    [Abstract] [Full Text] [Related]

  • 20. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA, Sabouni MH, Ansari AF, Lokhandwala MF.
    J Pharmacol Exp Ther; 1986 Aug 10; 238(2):547-53. PubMed ID: 2874213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.